Advancing the treatment of HIV/AIDS until there is a cure | Jim Demarest at TEDxElonUniversity

February 22, 2014 9:02 pm
More videos

In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.* (*Subject to certain rules and regulations)

Jim Demarest joined ViiV Healthcare at its inception in November 2009 as the Director of Microbiology Strategy. ViiV Healthcare was created by GlaxoSmithKline and Pfizer as a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV. Jim provides global oversight for the virology and immunology associated with pre- clinical and clinical phase compounds as well as marketed products. Prior to joining ViiV Healthcare, he spent more than 10 years at GlaxoSmithKline R&D (legacy GlaxoWellcome) where he was involved in the discovery and development of novel antivirals, immune-based therapies, and vaccines for the treatment of HIV-1 infection. Jim earned his PhD from the George Washington University while conducting research at the National Institutes of Health/NIAID. He did a post-doctoral research fellowship at Duke University, where he is currently an Adjunct Assistant Professor. Jim Demarest discusses innovations focused on advancing novel treatments that require less frequent dosing and attempt to achieve HIV cure.